Education and Training for Research Personnel

The Office of Data Quality supports multiple educational opportunities and training requirements for DF/HCC research personnel. Our program includes maintaining the Human Subject Protection (HSP) and Good Clinical Practice (GCP) training through the CITI website, providing policy and regulatory training for new DF/HCC investigators, and coordinating an educational lecture series open to all DF/HCC institutions.

HSP and GCP Training

Per SOP EDU-100 (updates effective 2/28/17), DF/HCC requires that all individuals involved in human subject research are trained in Human Subject Protection (HSP) and Good Clinical Practice (GCP). 

DF/HCC administers HSP and GCP training through the Collaborative Institutional Training Initiative (CITI). This is an on-line course accessible via: For more information on using the CITI website, please see: Step by Step Instructions: CITI HSP & GCP.

*Alert: For information and guidance on the updated GCP Training Requirement effective February 28th, 2017, please see here: DF/HCC Updated GCP Training Requirement Guidance & FAQ

HSP and GCP Staff Training Lists

ODQ regularly posts updated lists of active clinical research staff's training completion and expiration dates.


Frequently Asked Questions - HSP and GCP Training

New Investigator Training

Principal and Site-Responsible  Investigators that are new to conducting research at DF/HCC are required to complete the New Investigator Training, per EDU-100: Training Requirements for Research Personnel.

Please contact with any questions regarding this training requirement.

eLearning Center

Welcome to eLearning Center, an online resource library that references key talks and general information that affects investigators and research staff across Dana-Farber/Harvard Cancer Center. These educational materials are available to help you with your day-to-day clinical research responsibilities.

Recorded Presentations

January 12, 2018

"Clinical, Regulatory, Logistical, and Financial Aspects of CAR-T and other Novel Cell Therapies"
Sarah Nikiforow, MD, PhD
Clinical Instructor, Stem Cell Transplantation Program
Asst. Medical Director, Cell Manipulation Core Facility
Dana-Farber Cancer Institute


April 29, 2016

"Ethical Issues Related to Research Biopsies and Stored Biospecimens"
Jeffrey Peppercorn, MD, MPH
Associate Professor of Medicine,
Massachusetts General Hospital


MARCH 21, 2016

"Non-Clinical Research"
Sara Harnish, J.D.
Associate Director for Non-Clinical Research
Office for Human Research Studies


January 22, 2016

"Unanticipated Problems and Adverse Events"
Michele Russell-Einhorn, JD


Cultural Competency Training for new DF/HCC researchers

With growing concerns about racial and ethnic disparities in cancer care and the need for cancer centers to accommodate increasingly diverse patient populations, it is important that health care professionals are educated on how their own and their patients' culture influence health care delivery, health behaviors, and access to clinical trials. This self-directed program will stimulate your thinking about cultural competence and help you to understand how culture influences health care decisions and participation in clinical trials.

Part I: Reflections on Cultural Competence in Cancer Care

View below (speaker: Christopher Lathan, MD)